Rogue Scholar

Published December 5, 2008 in Front Matter

Direct to consumer advertising (DTCA) – advertising for prescription drugs – is only allowed in the United States (since 1997, when restrictions were loosened) and New Zealand. Drug companies pay for direct to consumer advertising (more than $4 billion in 2005 (Donohue 2007)) because they believe that it increases prescription rates.

References

General Medicine

A Decade of Direct-to-Consumer Advertising of Prescription Drugs

https://doi.org/10.1056/nejmsa070502

Published August 16, 2007 in New England Journal of Medicine

Authors Julie M. Donohue, Marisa Cevasco, Meredith B. Rosenthal

General EngineeringGeneral Earth and Planetary SciencesGeneral Environmental ScienceGeneral Medicine

Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study

https://doi.org/10.1136/bmj.a1055

Published September 2, 2008 in BMJ

Authors M. R Law, S. R Majumdar, S. B Soumerai

Open access is not enough – the source is also important

References

A Decade of Direct-to-Consumer Advertising of Prescription Drugs

Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study